High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$2.0M
$1,978,864
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Ambrose Kristen
• Officer • SVP & Chief Accounting Officer
10b5-1 Sell
2026-02-26
$172,560
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • SVP & Chief Accounting Officer
10b5-1 Sell
|
2026-02-26 | $172,560 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Ambrose Kristen
• Officer • SVP & Chief Accounting Officer
10b5-1 Sell
2026-02-25
$108,456
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • SVP & Chief Accounting Officer
10b5-1 Sell
|
2026-02-25 | $108,456 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Ambrose Kristen
• Officer • SVP & Chief Accounting Officer
10b5-1 Sell
2026-02-18
$302,208
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • SVP & Chief Accounting Officer
10b5-1 Sell
|
2026-02-18 | $302,208 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Ambrose Kristen
• Officer • SVP & Chief Accounting Officer
10b5-1 SellΔOwn -15.7%
2026-02-17
$762,089
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • SVP & Chief Accounting Officer
10b5-1 SellΔOwn -15.7%
|
2026-02-17 | $762,089 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Ambrose Kristen
• Officer • SVP & Chief Accounting Officer
10b5-1 SellΔOwn -12.0%
2026-02-11
$633,552
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • SVP & Chief Accounting Officer
10b5-1 SellΔOwn -12.0%
|
2026-02-11 | $633,552 | S | Form 4 |